In a research report issued today, Roth Capital analyst Debjit Chattopadhyay reiterated a Buy rating on Alcobra Ltd (NASDAQ:ADHD) with a price target of $40.00, …
In a research report released today, Canaccord analyst John Newman reiterated a Buy rating on shares of NPS Pharma (NASDAQ:NPSP) with a $42 price target, following concerns …
In a report published today, Cantor Fitzergald analyst Youssef Squali maintained a Buy rating on Yahoo! (NASDAQ:YHOO) and raised his price target to …
In a special research report released today, Cantor Fitzgerald analyst Youssef Squali initiated a Buy rating on Alibaba Group (NYSE:BABA) with a $90 price target, ahead …
In a research report issued today, Brean Capital analyst Jonathan Aschoff reiterated a Buy rating on Repros Therapeutics (NASDAQ:RPRX) with a price target …
In a research report issued today, H.C.
In a research note published today, H.C.
In a research report issued today, Roth Capital analyst Scott Henry assigned a Buy rating on Catalyst Pharmaceutical (NASDAQ:CPRX) with a $5.00 price …
In a research report issued today, Brean Capital analyst Jonathan Aschoff reiterated a Buy rating on NPS Pharmaceuticals (NASDAQ:NPSP) with a $41 price …